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mg2 +  is the second-most abundant cation in animal cells and is an essential cofactor in numerous 
enzymatic reactions. The molecular mechanisms controlling mg2 +  balance in the organism are 
not well understood. In this study, we report identification of TRPm7, a bifunctional protein 
containing a protein kinase fused to an ion channel, as a key regulator of whole body mg2 +  
homeostasis in mammals. We generated TRPm7-deficient mice with the deletion of the kinase 
domain.  Homozygous  TRPm7∆kinase  mice  demonstrated  early  embryonic  lethality,  whereas 
heterozygous mice were viable, but developed signs of hypomagnesaemia and revealed a defect 
in intestinal mg2 +  absorption. Cells derived from heterozygous TRPm7∆kinase mice demonstrated 
reduced TRPm7 currents that had increased sensitivity to the inhibition by mg2 + . Embryonic 
stem cells lacking TRPm7 kinase domain displayed a proliferation arrest phenotype that can 
be rescued by mg2 +  supplementation. our results demonstrate that TRPm7 is essential for the 
control of cellular and whole body mg2 +  homeostasis. 
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I
t was recently suggested1 that Mg2 +  uptake in mammalian cells is 
mediated by the channel kinases TRPM72,3 and TRPM64,5, which 
are unusual bifunctional molecules representing the only known 
vertebrate proteins consisting of an ion channel fused to a pro-
tein kinase. Under physiological conditions, TRPM7 passes weak 
inward current and is permeable to a number of divalent metal cati-
ons, including Mg2 +  and Ca2 + , as well as trace metal ions such as 
Mn2 + , Co2 +  and Zn2 +  (refs 3, 6). The current is inhibited by free 
Mg2 +  or Mg·ATP3. The kinase catalytic domain of TRPM7 belongs 
to the family of atypical protein kinases known as alpha kinases7–9. 
Deficiency of TRPM7 in DT-40 chicken lymphoma cells results in 
cell cycle arrest; the proliferation of these cells can be rescued by 
increasing the extracellular magnesium concentration1. It was sug-
gested that the channel part of TRPM7 can serve as a major Mg2 +  
uptake pathway into the cell, whereas the changes of magnesium 
concentration in the proximity of the channel pore can regulate the 
activity of the kinase domain1,10.
In this study, we report the construction of knockout mice with 
the deletion of TRPM7 kinase domain. We found that although 
homozygous knockout mice resulted in embryonic lethality, hetero-
zygous knockout mice were viable, but displayed abnormality in the 
regulation of Mg2 +  homeostasis and a defect in the intestinal Mg2 +  
absorption. We also found that embryonic stem (ES) cells lacking 
TRPM7 kinase domain displayed a proliferation arrest phenotype 
that can be rescued by supplementation of extracellular Mg2 + . Our 
results show that TRPM7 has an essential role in the regulation of 
both cellular and whole body Mg2 +  homeostasis.
Results
Deletion of TRPM7 kinase domain causes embryonic lethality. 
To study the role of TRPM7 and its kinase domain in the regulation 
of Mg2 +  homeostasis in the context of the whole organism, we used a 
genetic approach by creating a mouse strain with a disruption of the 
kinase part of the TRPM7 gene. The knockout mice were obtained 
using a gene-targeting vector technique with further mouse colony 
generation (Fig. 1a). The gene-targeting vector was prepared using 
an in vivo recombination strategy. To disrupt the kinase part of 
TRPM7, the targeting vector was constructed for the replacement 
of exons 32–36 with the neomycin resistance gene cassette (Fig. 1a).   
As  a  result  of  this  strategy,  the  TRPM7  protein  is  truncated 
immediately  upstream  of  the  alpha-kinase  domain.  Subsequent 
reverse transcription–PCR analysis of ES cells revealed that this 
truncation does not disrupt transcription/stability of mutant Trpm7 
mRNA, which encodes a protein containing amino acids 1–1,537 of 
TRPM7 (see Methods section). The chimeric mice were generated 
and resulted in germline transmission of the Trpm7 gene with the 
disrupted kinase domain (TRPM7∆kinase).
Out  of  62  TRPM7∆kinase  mice  born  from  heterozygous  inter-
crosses, none were homozygous knockout mice. Thus, knockout 
of TRPM7 kinase domain results in embryonic lethality. The ratio 
of wild type to heterozygous embryos was 22:40. It was consistent 
with the expected Mendelian ratio of 1:2 in the absence of knock-
out  embryos.  To  determine  the  developmental  stage  at  which 
TRPM7 kinase domain is required, we carried out timed hetero-
zygous crossings. At 8.5 days post coitum, we observed a set of a 
morphologically normal embryos and a number of morphologi-
cally abnormal small necrotic embryos. All normal embryos were 
either heterozygous or wild type. At 7.5 days post coitum, we found 
TRPM7∆kinase/∆kinase embryos that were smaller in comparison with 
the TRPM7 + /∆kinase or wild-type embryos. These embryos were at the 
advanced primitive streak stage (Fig. 1c). TRPM7∆kinase null embryos 
initiated gastrulation and mesoderm formation, as assessed by nor-
mal Brachyury staining (Fig. 1c). Thus, TRPM7∆kinase null embryos 
proceeded through a full day of gastrulation before their arrest. The 
early embryonic lethality of TRPM7∆kinase null embryos suggests that 
the intact kinase domain of TRPM7 is necessary for normal mouse 
embryonic  development.  In  contrast  to  homozygous  knockout 
mice, heterozygous TRPM7 + /∆kinase mice were viable, which allowed 
for the analysis of the phenotype of these mice.
TRPM7 + /kinase mice exhibit altered magnesium homeostasis. As 
TRPM7 was implicated in the regulation of magnesium homeo-
stasis, we analysed the magnesium status of TRPM7 + /∆kinase mice. 
In initial experiments, we used 8- to 9-month-old mice maintained 
on PicoLab Mouse Diet 20 containing 0.17% Mg2 + . We found that, 
in comparison with the wild-type mice, TRPM7 + /∆kinase mice had a 
significantly lower Mg2 +  concentration in plasma, urine and bones 
(Table 1). These results demonstrate that heterozygous TRPM7 + /∆kinase   
Table 1 | Mg2 +  concentration in wild-type and TRPM7 + /kinase 
male mice fed PicoLab Mouse Diet 20.
TRPM7 wild type TRPM7 + /kinase
Plasma mg2 + , mmol l − 1 0.86 ± 0.03 (10) 0.75 ± 0.03 (9)*
Erythrocytes mg2 + , mmol l − 1 2.13 ± 0.05 (10) 2.07 ± 0.04 (9)
Bones mg2 + , mmol kg − 1 117.4 ± 2.8 (10) 105.6 ± 2.2 (9)*
urine mg2 + , mg per 24 h 0.40 ± 0.1 (9) 0.07 ± 0.03 (6)*
mg2 +  values are means ± s.e.m. with number of animals in parentheses. statistical analysis was 
performed by student’s t-test.
*significantly different from wild-type mice, P < 0.05.
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Figure 1 | Generation of TRPM7-deficient mice. (a) A schematic 
representation of TRPm7 protein. Arrow indicates the position of 
truncation in TRPm7∆kinase mice. Also shown are the structures of the 
murine TRPm7 locus, targeting vector and resulting homologous 
recombination locus. (b) southern blot analysis of genomic DnA from 
wild-type ( + / + ) or TRPm7 + /∆kinase ( + / − ) mice after digestion with NcoI. 
(c) TRPm7 + /∆kinase ( + / − ) and TRPm7∆kinase/∆kinase ( − / − ) embryos at 7.5 days 
post coitum. staining with Brachyury antisense mRnA marks the primitive 
streak, where mesoderm formation occurs, and demonstrates that 
embryos are at the advanced primitive streak stage. scale bar, 100 µm.ARTICLE     
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mice have altered Mg2 +  regulation. Furthermore, the response to 
the Mg2 + -deficient diet was evaluated in the heterozygous TRPM7 
kinase-deficient mice. The subsequent experiments were performed 
with 4-month-old mice maintained on semipurified diets described   
in the Methods section. TRPM7 + /∆kinase mice and wild-type mice 
were  placed  on  control  and  Mg2 + -deficient  diets  with  0.1  and 
0.003% Mg2 + , respectively. They were fed these diets for 14 days 
before taking blood and bone samples. The results of these experi-
ments revealed that with normal diet both groups of mice had no 
alterations in plasma or erythrocyte Mg2 +  concentration (Table 2). 
However, the TRPM7 + /∆kinase mice had lower levels of Mg2 +  in bones. 
When subjected to the Mg2 + -deficient diet for 14 days, TRPM7 + /∆kinase   
mice developed a greater decrease of Mg2 +  concentration in plasma, 
erythrocytes and bones than the wild-type mice (Table 2).
We  also  observed  a  significant  increase  in  mortality  in   
TRPM7 + /∆kinase mice, but not in wild-type mice placed on Mg2 + -
deficient diet (Fig. 2a). Also consistent with a higher sensitivity of 
TRPM7 + /∆kinase mice to the low dietary Mg2 + , after subjecting mice 
to 12 days of the Mg2 + -deficient diet, we observed severe clasping of 
the limbs in 6 out of 10 TRPM7 + /∆kinase mice (Fig. 2b). Among these 
six mice, three mice experienced seizures, and two mice exhibited 
tremor, slow movement in the cage and violent sudden leaps as a 
reaction to the light and noise. Clasping, tremor or seizures were 
never observed in 11 control wild-type mice placed on Mg2 + -defi-
cient diet for the same period of time. The early appearance of sei-
zures and clasping in TRPM7 + /∆kinase mice on Mg2 + -deficient diet 
suggests the faster development of hypomagnesaemic conditions in 
comparison with the wild-type mice.
Thus,  under  two  different  control  diet  conditions  (PicoLab 
Mouse Diet 20 or semipurified diet), the TRPM7 + /∆kinase mice dis-
play lower Mg2 +  bone storage. The difference in the results with 
plasma magnesium concentration between experiments described 
in Tables 1 and 2 is most likely related to the difference in mouse 
age and/or diet. Together with the observed higher sensitivity of the 
TRPM7 + /∆kinase mice to severe dietary magnesium deficiency, par-
ticularly lower plasma and erythrocyte Mg2 +  concentrations, lower 
magnesium storage in the bones and cases of seizures and clasping 
of the limbs, the phenotype of the TRPM7 + /∆kinase mice suggests that 
they have altered magnesium homeostasis.
It is known that low magnesium status conditions correlate with 
cell-extrinsic enhancement of systemic inflammatory and allergic   
responses11.  Therefore,  we  performed  oxazolone  sensitization 
experiments to evaluate the level of delayed-type hypersensitivity   
responses in TRPM7 + /∆kinase mice. One week before sensitization, 
wild-type and TRPM7 + /∆kinase mice were adapted to the control   
(0.1% Mg2 + ) diet. TRPM7 + /∆kinase mice placed on control diet, dis-
played  an  elevated  oxazolone  treatment  sensitivity  response, 
compared with wild-type animals (Fig. 2c). When wild-type and 
TRPM7 + /∆kinase mice were placed on Mg-deficient diet, the hypersen-
sitivity response was increased to a similar degree in both groups 
of animals (Fig. 2c). However, the placement of TRPM7 + /∆kinase  
mice on the Mg2 + -supplemented diet completely abrogated their 
hypersensitivity to oxazolone treatment, and both groups of mice 
displayed slightly lower responses compared with animals kept 
on the control diet (Fig. 2c). Therefore, the supplemental Mg2 +  
in the diet can lower the hypersensitivity reaction of the Mg2 + -
deficient TRPM7 + /∆kinase mice, consistent with the TRPM7 + /∆kinase  
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Figure 2 | Analysis of hypomagnesaemic phenotype in TRPM7 + /kinase 
mice. (a) survival of wild-type (TRPm7+ /+) mice (n = 30) or TRPm7 + /∆kinase 
mice (n = 30) on mg2 + -deficient diet. (b) Clasping test for the wild-
type and TRPm7 + /∆kinase mice subjected to mg2 + -free diet for 12 days. 
(c) The effect of TRPm7 deficiency and mg2 +  content in the diet on 
the oxazolone sensitivity reaction. The delayed sensitivity response is 
measured as a change in the ear thickness, mm. Before ear application 
of oxazolone, wild-type mice and TRPm7 + /∆kinase mice were fed for 7 days 
severely mg2 +  deficient, control and supplemental mg2 +  diet with 0.003, 
0.1 and 0.3% mg2 + , respectively. The swelling response was measured 
24 h after the challenge using an engineer’s micrometre. Calculations of 
the swelling response were carried out comparing with the respective 
control groups not exposed to oxazolone. All mice were 4 months old. 
open and shaded bars correspond to wild-type mice and TRPm7 + /∆kinase 
mice respectively. Values are means ± s.e.m. Two-way analysis of 
variance test was used for the calculations (n = 7–10 mice per group); 
P < 0.05. #significantly different from wild-type mice fed a respective 
diet. *significantly different from respective wild-type or TRPm7 + /∆kinase 
mice fed a control 0.1% mg diet. (d) Analysis of mg2 +  content in feces 
of the wild type mice (n = 6) and TRPm7 + /∆kinase mice (n = 6). mice were 
maintained on normal diet (0.1% mg2 + ). Values are means ± s.e.m. 
statistical analysis was performed by student’s t-test. *significantly 
different (P < 0.05).
Table 2 | Mg2 +  concentration in wild-type and TRPM7 + /kinase mice fed diets with different Mg2 +  concentrations.
Diet Wild type TRPM7 +  /∆kinase
0.3% Mg2 +  0.1% Mg2 +  0.003% Mg2 +  0.3% Mg2 +  0.1% Mg2 +  0.003% Mg2 + 
Plasma mg2 + , mmol l − 1 7 days 0.86 ± 0.04 (12) 0.80 ± 0.02 (16) 0.2 ± 0.01 (5)* 0.87 ± 0.04 (13) 0.76 ± 0.02 (14) 0.14 ± 0.02 (5)*#
14 days nA 0.80 ± 0.03 (12) 0.17 ± 0.03 (6)* nA 0.76 ± 0.04 (11) 0.09 ± 0.01 (7)*#
Erythrocytes mg2 + , mmol l − 1 7 days 2.05 ± 0.05 (12) 2.17 ± 0.07 (13) 1.72 ± 0.09 (6)* 2.09 ± 0.04 (13) 2.12 ± 0.06 (14) 1.5 ± 0.12 (6)*
14 days nA 2.14 ± 0.07 (13) 1.44 ± 0.09 (7)* nA 2.23 ± 0.08 (12) 0.95 ± 0.05 (7)*#
Bones mg2 + , mmol kg − 1 7 days 116 ± 5.8 (5) 103.5 ± 1.7 (6) 100.4 ± 2.3 (6) 98.4 ± 2.1 (7)# 91 ± 2.7 (7) 81.6 ± 7.3 (5)#
14 days nA 103.27 ± 2.95 (12) 89.27 ± 3.21 (7)* nA 92.46 ± 2.43 (12)# 79.99 ± 1.78 (6)*#
Abbreviation: nA, not applicable.
mg2 +  values are means ± s.e.m. with number of animals in parentheses. statistical analysis was performed by two-way analysis of variance followed by Tukey’s test, P < 0.05.
#significantly different from wild-type mice fed a respective diet.
*significantly different from respective wild-type or TRPm7 + /∆kinase mice fed a control 0.1% mg2 +  diet.ARTICLE
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phenotype  reflecting  a  sequelae  of  systemic  low  magnesium   
status  as  opposed  to  alterations  in  cellular  physiology  because   
of deficient TRPM7 function.
Low  magnesium  status  can  arise  from  decreased  intestinal 
Mg2 +  absorption, increased renal secretion or a combination of the 
two. Although renal excretion of Mg2 +  in TRPM7 + /∆kinase mice was 
decreased (see Table 1), it cannot be easily determined whether 
this  reflects  a  normal  compensatory  physiological  response  to 
preserve Mg2 +  during hypomagnesaemia or represents an inad-
equate compensation because of reduced TRPM7 function in our 
TRPM7 + /∆kinase model. However, the effect of TRPM7 deficiency 
on  intestinal  Mg2 +   absorption  can  be  easily  and  quantitatively 
assessed by analysing Mg2 +  content in feces from TRPM7 + /∆kinase 
mice kept on a normal diet. As can be seen in Figure 2d, there 
was significantly higher Mg2 +  excretion in feces in TRPM7 + /∆kinase 
mice in comparison with the wild-type mice (increase of 22.7%, 
P = 0.0381), indicating that TRPM7 deficiency results in decreased 
intestinal Mg2 +  absorption.
Deletion of the kinase domain alters TRPM7 channel properties. 
Although we disrupted the kinase encoding part of TRPM7 gene, 
it is possible that this disruption affects channel function, as it was 
shown that the absence of the kinase domain affects TRPM7 chan-
nel sensitivity to Mg2 +  inhibition1,12. To investigate TRPM7 chan-
nel activity in TRPM7 + /∆kinase mice, we measured TRPM7 currents 
in peritoneal mast cells derived from mutant and wild-type mice 
(Fig. 3). We determined the relative expression levels of functional 
TRPM7 channels in the plasma membrane by recording whole-cell 
TRPM7-like MagNuM (magnesium nucleotide metal) currents3 of 
mast cells derived from wild-type and TRPM7-deficient mice. Cells 
were perfused with an intracellular solution supplemented with che-
lators for Ca2 +  and Mg2 +  and superfused with divalent-free (DVF) 
external  solution  after  full  development  of  MagNuM  (Fig.  3a). 
Under these conditions, MagNuM currents linearized to a similar 
degree in both genotypes as described previously for heterologously 
expressed TRPM7 (ref. 1). Currents assessed at  − 80 and  + 80 mV 
showed that both genotypes had similar MagNuM current ampli-
tudes during DVF conditions, indicating that the degree of channel 
expression in the plasma membrane was not significantly altered. 
However, currents measured in cells from TRPM7 + /∆kinase mutant 
mice were slightly suppressed at positive potentials (Fig. 3b) com-
pared  with  wild-type  mice.  The  current  ratio  calculated  at   + 80 
and  − 80 mV during DVF conditions was 0.72 for wild-type and 
0.66 for TRPM7 + /∆kinase mice. This slight suppression between wild 
type and TRPM7 + /∆kinase was not caused by a change in selectivity, 
as the reversal potential was not significantly different in the two 
genotypes (wild type  − 7.6 ± 1.2 mV; TRPM7 + /∆kinase  − 4.9 ± 1.2 mV, 
P < 0.15) (Fig. 3b).
We next analysed the effect of 2-aminoethyl diphenylborinate 
(2-APB), an inhibitor of TRPM7, and found that its application 
reduced current amplitudes in wild-type and TRPM7 + /∆kinase cells 
to a similar degree (Fig. 3c), indicating that the current was indeed   
carried by TRPM7 channels and that 2-APB sensitivity was not 
lost in mutant mast cells13. MagNuM currents of TRPM7 + /∆kinase 
cells were significantly reduced, developing only half the ampli-
tudes observed in wild-type mast cells (Fig. 3c). The comparison of 
the current/voltage (I/V) relationships illustrates the reduced cur-
rent amplitudes for TRPM7 + /∆kinase cells compared with wild type   
(Fig. 3d). As TRPM7 + /∆kinase cells express a similar amount of TRPM7 
channels in the plasma membrane as wild-type mast cells (Fig. 3a and 
b), the reduction of current magnitude in TRPM7 + /∆kinase cells could   
be due to enhanced sensitivity of the channels to regulatory inhibi-
tors, such as divalent ions, as half of TRPM7 molecules expressed 
in these cells are expected to lack the alpha-kinase domain. It has 
been shown that TRPM7 currents can be inhibited by extracellular 
magnesium14. We therefore assessed the sensitivity of MagNuM to 
removal of extracellular Mg2 + . As Figure 3e demonstrates, replacing 
Mg2 +  with Ca2 +  enhanced the current response at positive poten-
tials 2.5-fold for the wild-type and the mutant types of channels. 
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Figure 3 | TRPM7 (MagNuM) currents in mast cells derived from 
TRPM7-deficient mice. (a) Average normalized time course of magnum 
current development in mouse mast cells isolated from wild-type (black 
circles, n = 15) and TRPm7 + /∆kinase mice (red circles, n = 11). Currents were 
elicited by a ramp protocol from  − 100 to  + 100 mV over 50 ms acquired 
at 0.5 Hz. Inward current amplitudes were extracted at  − 80 mV, outward 
currents at  + 80 mV and plotted versus time of the experiment. Data 
were normalized to cell size as pA/pF. Error bars indicate s.e.m. The 
composition of extracellular, intracellular and application solutions are 
described in methods section. (b) Average current–voltage (I/V) curves 
extracted from a representative wild-type cell (black) and TRPm7 + /∆kinase 
(red) extracted at 200 s. (c) Average normalized time course of magnum 
current development in mouse mast cells isolated from wild-type (black 
circles, n = 10) and TRPm7 + /∆kinase mice (red circles, n = 12). Data were 
acquired and analysed as in a. At the time indicated by the black bar, cells 
were superfused with external solution supplemented with 50 µm 2-APB. 
(d) Current–voltage (I/V) curves extracted from a representative wild-
type cell (black) and TRPm7 + /∆kinase (red). (e) Average normalized time 
course of magnum current development in mouse mast cells isolated 
from wild-type (black circles, n = 14) and TRPm7 + /∆kinase mice (red circles, 
n = 9). Data were acquired as in a and normalized as I/I390 s. Experimental 
solutions as in a, except for the application solution that contained (in mm) 
150 naCl, 2.8 KCl, 3 CaCl2, 10 HEPEs–naoH. Extracellular solution was 
nominally mg2 +  free, and applied for the time indicated by the black bar. 
Internal solution contained 10 mm Cs-BAPTA instead of Cs-EGTA.  
(f) Dose–response curve of magnum currents to intracellular mg2 +  
measured in mouse mast cells isolated from wild-type (black circles,  
n = 5–11) or TRPm7 + /∆kinase mice (red circles, n = 5–10). Error bars indicate 
s.e.m. Current amplitudes assessed at  + 80 mV and extracted at 300 s  
into the experiment. Intracellular mg was (in µm) 0 (nominally free),  
40 (31 free), 150 (116 free), 300 (233 free), 650 (507 free),  
1,000 (781 free), and was calculated using WebmAXC.ARTICLE     
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Concentration–response curves of MagNuM currents for intracel-
lular Mg2 +  in mast cells, isolated from wild-type or TRPM7 + /∆kinase 
mice, show that MagNuM currents in TRPM7 + /∆kinase mast cells 
were  about  two-fold  more  sensitive  to  the  inhibition  by  intra-
cellular Mg2 +  (wild type IC50 = 170 µM, Hill = 1.8; TRPM7 + /∆kinase 
IC50 = 90 µM, Hill = 1.2; Fig. 3f), indicating that the absence of one 
allele of the TRPM7 kinase is sufficient to increase the sensitivity 
to intracellular Mg2 +  dramatically. This is in good agreement with 
previous work, in which deletion of the TRPM7 kinase domain 
increased  sensitivity  of  TRPM7  to  inhibition  by  intracellular   
Mg2 +  (refs 1, 12).
Next, we decided to investigate TRPM7∆kinase null ES cells. We 
obtained ES cells from blastocysts of TRPM7 + /∆kinase females after 
mating them with TRPM7 + /∆kinase males. First, we measured the 
surface expression of TRPM7 in ES cells of all three obtained gen-
otypes: wild type, heterozygous TRPM7 + /∆kinase and homozygous 
TRPM7∆kinase/∆kinase. MagNuM currents observed in wild-type and 
heterozygous TRPM7 + /∆kinase ES cells (Fig. 4) were similar to those 
obtained in peritoneal mast cells (Fig. 3). ES cells were perfused 
with an intracellular solution supplemented with chelators for 
Ca2 +  and Mg2 +  and superfused with DVF external solution after 
full development of MagNuM (Fig. 4a). Under these conditions, 
MagNuM currents linearized to a similar degree in wild-type and 
TRPM7 + /∆kinase mutant cells, indicating that the level of channel 
expression in the plasma membrane was not significantly altered. 
However, in TRPM7∆kinase/∆kinase ES cells, DVF application resulted 
in much lower current amplitudes (5.5-fold) compared with wild 
type, suggesting a decreased expression of functional channels 
in the plasma membrane. The current ratio calculated at  + 80 
and  − 80 mV during DVF conditions was 0.90 for wild type, 0.82 
for TRPM7 + /∆kinase and 1.22 for TRPM7∆kinase/∆kinase ES cells. Simi-
lar to our results obtained in mast cells, MagNuM currents for 
TRPM7 + /∆kinase ES cells were significantly reduced compared with 
wild-type  ES  cells,  whereas  TRPM7∆kinase/∆kinase  ES  cells  showed 
almost no MagNuM currents at all (Fig. 4c). The comparison of 
the I/V relationships illustrates the reduced current amplitudes 
for  TRPM7 + /∆kinase  and  TRPM7∆kinase/∆kinase  cells  compared  with 
wild  type  (Fig.  4d).  Thus,  our  electrophysiological  studies  of 
mast cells and ES cells suggest that the deletion of TRPM7 kinase 
domain reduces channel activity and increases its sensitivity to   
magnesium inhibition.
Supplemental Mg2 +  rescues growth of TRPM7-deficient ES cells. 
To test whether the growth pattern and magnesium requirements 
are changed in the mutant ES cells, equal amounts of wild-type, 
heterozygous TRPM7 + /∆kinase and homozygous TRPM7∆kinase/∆kinase ES 
cells were grown in control ES-Dulbecco’s modified Eagle’s medium 
(DMEM) and ES-DMEM supplemented with 10 mM MgCl2. After 
72 h of growth, the ES cells were observed and images were taken 
using phase-contrast microscopy. As Figure 5 demonstrates, at 72 h 
after plating, ES homozygous TRPM7∆kinase/∆kinase cells did not grow 
significantly in the control media containing 1 mM MgCl2. However, 
supplementation with 10 mM MgCl2 rescued the growth inhibition 
phenotype of TRPM7∆kinase/∆kinase ES cells. TRPM7∆kinase/∆kinase ES cells 
grown in 10 mM MgCl2 appeared as healthy and confluent as wild-
type ES cells grown in 1 mM MgCl2 control media for 72 h. When 
the concentration of MgCl2 in the media was increased from 1 mM 
to 10 mM, the ES TRPM7∆kinase/∆kinase cell growth fully recovered and 
confluence was reached in 48 h. The heterozygous ES cells presented 
an intermediate growth inhibition effect in media containing 1 mM 
MgCl2. These results suggest that TRPM7 has an essential role in the 
proliferation of ES cells probably by providing the necessary Mg2 +  
influx. Interestingly, we found that ES cells express TRPM6 mRNA 
and its level was similar in wild-type and TRPM7∆kinase/∆kinase cells 
(Supplementary Fig. S1). These results suggest that TRPM6 cannot 
compensate the deficiency of TRPM7 in ES cells.
Discussion
Our results that TRPM7 deficiency in ES cells leads to the inhibi-
tion of proliferation are consistent with previous reports, showing 
that deletion of TRPM7 in DT-40 cells arrests cell cycle progres-
sion. It was demonstrated that at standard magnesium concentra-
tion TRPM7-deficient DT-40 cells become arrested in a quiescent 
G0-like state15. They can be induced to progress through cell cycle 
by increasing extracellular magnesium concentration1 or by over-
expressing  SLC41A2  magnesium  transporter16.  What  can  be  the 
role of TRPM7 in cell proliferation? Free magnesium represents 
only 1–2% of total intracellular magnesium17 and most intracellu-
lar magnesium is bound to ATP, other nucleotide phosphates, RNA, 
proteins and membranes. As most cell constituents are doubled in 
their amount during G1 phase of the cell cycle, it is expected that 
a large amount of additional magnesium is needed to bind newly 
synthesized molecules. This explains why reduction of extracellu-
lar magnesium inhibits cell proliferation18–20 and why magnesium 
is required specifically during G1 phase of the cell cycle18. Interest-
ingly, it was shown that TRPM7 current is kept at a low level at G0, 
S, G2 and M phases of the cell cycle and becomes activated specifi-
cally during G1 phase21. Therefore, it is likely that TRPM7 mediates 
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Figure 4 | TRPM7 (MagNuM) currents in ES cells derived from TRPM7 
deficient mice. (a) Average normalized time course of TRPm7 current 
development in mouse Es cells isolated from wild-type (black circles, 
n = 13), TRPm7 + /∆kinase (red circles, n = 12) and TRPm7∆kinase/∆kinase  
mice (blue circles, n = 13). Data were acquired and analysed as in Figure 3a.  
Error bars indicate s.e.m. The intracellular solution was divalent-free and 
contained (in mm) 140 Cs-glutamate, 8 naCl, 10 Cs-EGTA, 5 na-EDTA 
(pH 7.2, 300 mosm). The extracellular solution contained (in mm) 140 
naCl, 1 CaCl2, 2.8 KCl, 2 mgCl2, 10 HEPEs–naoH, 11 glucose (pH 7.2, 
300 mosm). The application solution contained (in mm) 150 mm naCl, 
2.8 KCl, 10 HEPEs–naoH, 0.5 na-EDTA. (b) Average current–voltage (I/V)  
curves from a representative wild-type cell (black), TRPm7 + /∆kinase (red) 
and TRPm7∆kinase/∆kinase (blue) extracted at 200 s. (c) Average normalized 
time course of magnum current development in mouse Es cells isolated 
from wild-type (black circles, n = 8), TRPm7 + /∆kinase mice (red circles, 
n = 10) and TRPm7∆kinase/∆kinase mice (blue circles, n = 10). Data were acquired 
and analysed as in a. At the time indicated by the black bar, cells were 
superfused with external solution supplemented with 50 µm 2-APB.  
(d) Current–voltage (I/V) curves extracted from a representative wild-type 
cell (black), TRPm7 + /∆kinase (red) and TRPm7∆kinase/∆kinase (blue).ARTICLE
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magnesium influx during G1 phase of the cell cycle and this repre-
sents its primary function in the regulation of cellular magnesium 
homeostasis.
In addition to its role in the regulation of cellular magnesium 
homeostasis in proliferating cells, our results suggest that TRPM7 
also has a key role in the regulation of whole body Mg2 +  balance. It 
has been previously proposed that another channel kinase TRPM6 
regulates Mg2 +  homeostasis at the level of the organism1,4,5. Indeed, 
only mutations in TRPM6 but not TRPM7 have been reported in 
patients with hypomagnesaemia. However, observations by Chu-
banov et al.22,23 subsequently suggested a refined model, in which 
TRPM6 exerts its action on Mg2 +  absorption through heteromul-
timeric channels formed in association with TRPM7, as TRPM6 
was found to be unable to assemble functional channels unless 
coexpressed with TRPM7 (refs 22, 23). Our results would be con-
sistent with this refined model, as we observe a defect in intesti-
nal Mg2 +  absorption in TRPM7 + /∆kinase mice, reminiscent of that 
observed in TRPM6-deficient patients, although we cannot exclude   
an additional deficit in Mg2 +  uptake through dysregulated TRPM7 
homomultimeric channels as well. Interestingly, magnesium uri-
nary  excretion  values  are  significantly  lower  in  TRPM7 + /∆kinase 
mice (see Table 1), suggesting that either deletion of the kinase 
domain does not negatively affect TRPM7 + /∆kinase function in the 
kidney or that TRPM7 + /∆kinase mice activate some compensatory 
mechanisms that help increase magnesium reabsorbtion in the 
kidney.  Recently,  Walder  et  al.24  demonstrated  that  TRPM6 + /- 
mice had lower plasma Mg2 +  levels, but no difference in urinary 
or fecal Mg2 +  concentrations compared with wild-type mice. In   
comparison, TRPM7 + /∆kinase mice had a significant increase in Mg2 +  
excretion in feces suggesting that TRPM7 deficiency in mice has a 
stronger effect on intestinal Mg2 +  absorption than TRPM6 deficiency. 
Taken together, our results indicate that (1) impaired function of 
TRPM7 conductance results in dysregulation of Mg2 +  homeostasis 
in mammalian organisms; (2) TRPM6 cannot compensate for the 
decrease in TRPM7 channel or the loss of TRPM7 kinase function, 
but conversely TRPM7 may interfere with functional TRPM6 chan-
nels by forming heteromultimeric channels; (3) the loss of the TRPM7 
kinase  domain  might  trigger  further  yet  unknown  mechanisms,   
culminating in a low magnesium, hyperallergic phenotype.
Our results are consistent with the following model of TRPM7 
functioning. At the cellular level, TRPM7 may serve as an Mg2 +  
channel, in which activity is regulated by intracellular Mg2 +  through 
a negative feedback mechanism. TRPM7 is particularly important 
to ensure a rapid Mg2 +  entry during G1 phase of the cell cycle. 
Therefore, deficiency of TRPM7 in DT-40 cells or ES cells results 
in the arrest of cell proliferation because of the inability to traverse 
the G1 phase of the cell cycle. Our results suggest that TRPM7 is 
also involved in whole body Mg2 +  homeostasis. Whole body Mg2 +  
influx is provided by Mg2 +  absorption in the intestine and reabsorb-
tion in the kidney. We found that TRPM7 is essential for normal 
Mg2 +  absorption in the intestine. This suggests that in cells medi-
ating  transcellular  magnesium  transport  TRPM7  is  active  even 
in  non-proliferating  cells.  Therefore,  there  should  be  additional 
mechanisms that activate TRPM7 in tissues with transcellular Mg2 +  
transport. As TRPM6 is expressed predominantly in the intestine 
and kidney and can form heteromeric complexes with and activate 
0
0
50
100
150
(
c
e
l
l
/
m
l
)
 
×
1
0
4
200
a
b
1 mM
10 mM
Mg2+
1
Days
trpm7
+/+
10 mM MgCl2
1 mM MgCl2
2 3 0
0
50
100
150
(
c
e
l
l
/
m
l
)
 
×
1
0
4
200
1
Days
trpm7
+/�kinase
2 3 0
0
50
100
150
(
c
e
l
l
/
m
l
)
 
×
1
0
4
200
1
Days
trpm7
�kinase/�kinase
trpm7
+/+ trpm7
+/�kinase trpm7
�kinase/�kinase
2 3
Figure 5 | Mg2 +  supplementation rescues the growth arrest phenotype of TRPM7 deficient ES cells. Equal amounts (2.2 × 105 per well) of wild-type, 
TRPm7 + /∆kinase and TRPm7∆kinase/∆kinase Es cells were plated in six-well plates in 2 ml of the control Es-DmEm and Es-DmEm supplemented with 10 mm 
mgCl2. (a) Phase-contrast images were taken after 72 h of growth. scale bar, 200 µm. (b) Growth curves. number of Es cells were quantified at different 
time points. Error bars indicate s.e.m., n = 3.ARTICLE     

nATuRE CommunICATIons | DoI: 10.1038/ncomms1108
nATuRE CommunICATIons | 1:109 | DoI: 10.1038/ncomms1108 | www.nature.com/naturecommunications
© 2010 Macmillan Publishers Limited. All rights reserved.
TRPM7 (ref. 22), it is tempting to suggest that the primary function 
of TRPM6 may be to enhance the function of TRPM7 in tissues 
with transcellular magnesium transport. In addition, the expression 
of TRPM6 in ES cells (see Supplementary Fig. S1) and during early 
embryonic development24 may be related to the requirement of rapidly 
dividing cells of the embryo for high amounts of Mg2 + .
Taken  together,  our  data  show  that  TRPM7  is  essential  for 
embryonic  development  and  systemic  Mg2 +   homeostasis  in  a 
mammalian organism. The latter result is in contrast to a recent 
study25, in which a targeted deletion of TRPM7 in mouse thymic 
medullary cells reportedly did not alter acute uptake of Mg2 +  or 
maintenance of total cellular Mg2 + . It was therefore concluded that 
TRPM7 is not essential for cellular Mg2 +  homeostasis in mice. One 
of the possible explanations of this discrepancy between their con-
clusions and ours is that Jin et al.25 analysed cells in a quiescent 
state, in which TRPM7 may not be important for the regulation 
of magnesium influx. Also the experimental approaches presented 
by Jin et al.25 are not clear-cut and may not be suitable to exclude 
Mg2 +  regulation as the critical defect. First, Mg2 +  influx was studied 
using the fluorescent indicator KMG104AM, and Mg2 +  influx was 
evaluated in the absence and presence of high extracellular Mg2 +  
in T lymphocytes isolated from wild-type and TRPM7-/fl(lck-Cre) 
mice. Although intracellular Mg2 +  increased during extracellular 
exposure to 10 mM Mg2 + , no difference in fluorescent signal, and 
therefore Mg2 +  influx, was found between wild-type and mutant 
cells. However, this is not an unexpected result, as it is not related 
to TRPM7 activity. Mg2 +  entering the cell through TRPM7 dur-
ing high extracellular Mg2 +  conditions will exert negative feed-
back inhibition on TRPM7 channels, thus shutting down channel 
activity and in turn suppress Mg2 +  influx within a few seconds6. 
Hence, the absence or presence of TRPM7 channels in mutant or 
wild-type T cells is irrelevant under high external Mg2 +  condi-
tions, and any increase in cellular Mg2 +  simply reflects Mg2 +  influx 
through  pathways  independent  of  TRPM7.  Therefore,  a  further 
pharmacological  suppression  by  2-APB  is  also  not  expected  to 
have any additional effects on Mg2 +  influx. The third experimental 
approach chosen by Jin et al.25 assessed differences in Mg2 +  influx 
in thymocytes isolated from wild-type and TRPM7-/fl(lck-Cre) mice 
during extracellular acidification, which causes a strong potentia-
tion of inward currents compared with outward currents assessed 
at  − 80 and  + 80 mV, respectively. However, this increase in inward 
ion flux does not translate into an increased Mg2 +  flux, as acidi-
fication causes a change in ion selectivity favouring monovalent 
over divalent ions. Importantly, decreases in extracellular pH do 
not affect divalent cation conductance26. Therefore, extracellular 
acidification experiments are not suited to assess changes in Mg2 +  
influx  through  TRPM7  channels.  Finally,  the  inability  to  detect 
differences in total cellular Mg2 +  between wild-type and TRPM7-
/fl(lck-Cre) T cells could indicate that steady-state levels of cellular 
Mg2 +  are not compromised and that these cells, given enough time, 
have mechanisms to regulate cellular Mg2 +  homeostasis, despite 
deficiencies in acute Mg2 +  influx, especially in light of the fact that 
the systemic Mg2 +  homeostasis and Mg2 +  plasma levels are not 
affected in TRPM7-/fl(lck-Cre) mice. The incomplete knock-out of 
TRPM7, in which reportedly a significant portion of T cells main-
tain TRPM7 expression25, would also allow for some regulation of 
Mg2 +  contents by TRPM7 in a subset of tested cells. In contrast, our 
use of a uniformly expressed TRPM7 hypomorphic allele allowed 
us to manipulate and analyse murine Mg2 +  physiology at the whole 
animal level, and we observe clear effects on systemic Mg2 +  home-
ostasis in association with deficient TRPM7 function.
Overall, our findings with mice genetically deficient in TRPM7 
function  represent  the  first  direct  evidence,  implicating  TRPM7 
in the control of whole body Mg2 +  levels, and place TRPM7 at the 
nexus of mechanisms that regulate both cellular and whole body 
Mg2 +  homeostasis.
Methods
Construction of TRPM7kinase mice. All animal procedures were approved by 
the Institutional Animal Care and Use Committee (IACUC) and adhered to 
principles outlined in the National Institutes of Health Guide for the Care and 
Use of Laboratory Animals. Experiments in A. Mazur laboratory were performed 
according to the guidelines of the INRA Ethics Committee, in accordance with 
decree no. 87–848.
The knockout mice were obtained using a gene-targeting vector technique 
for TRPM7 with further mice colony generation. The gene-targeting vector was 
prepared using an in vivo recombination strategy. To disrupt the kinase domain of 
the TRPM7, the targeting vector was constructed by using a short arm 1.3 kb DNA 
fragment of an intron located between exons 36 and 37. The short arm was a PCR 
fragment from AKASA2 to AKASA1. AKASA2 is located 222 bp downstream of 
exon 36, with a sequence of 5′-GTAACTTTCCTGCCCGAGTCTC-3′. AKASA1  
is located 116 bp upstream of exon 37 with a sequence of 5′-CTTATCTCTC 
AAGCCAATTTAGGAG-3′. The short arm was inserted into the 5′ of the Neo gene 
cassette using MluI site. The long arm was a 9.7 kb genomic fragment containing 
exons 28–31. In this strategy, exons 32–36 encoding the large portion of the kinase 
domain were replaced by the Neo gene cassette (Fig. 1). As a result, the TRPM7 
protein is truncated immediately upstream of the alpha-kinase domain. The reverse 
transcription–PCR analysis of ES knockout cells (see Supplementary Fig. S2) 
showed that TRPM7∆kinase protein contains TRPM7 amino acids 1–1,537 and an 
additional stretch of 48 amino acids with the following sequence: DLQRIDPLR 
RTRQEGDRRRCAANRERRYRKARGSGQPIRRQALQQYHG.
The targeting vector was linearized by NotI and then transfected by electro-
poration into 129 SV ES cells. After selection with G418, surviving colonies were 
expanded, and PCR analysis was performed to identify clones that had undergone 
homologous recombination. The correctly targeted ES cell lines were microin-
jected into C57BL/6J blastocysts. The chimeric mice were generated and resulted 
in germline transmission of the trpm7 gene with the disrupted kinase domain. 
The knockout of one allele in heterozygous TRPM7 + /∆kinase mice was confirmed 
by Southern blot analysis (Fig. 1b). Preparation of ES cells for construction of 
TRPM7∆kinase  mice and implantation were performed at inGenious Targeting  
Laboratory, Stony Brook, NY.
Isolation of the peritoneal mast cells and primary cell culture. Cells were  
isolated from the peritoneum of wild-type or TRPM7 + /∆kinase mice, collected in  
standard external saline through lavage of the abdomen, and centrifuged at 1,000  
r.p.m. for 10 min. The pellet was resuspended in 1 ml DMEM and placed into 
two Petri dishes with up to five poly-d-lysine-coated glass coverslips. Cells were 
cultured in 2 ml DMEM containing 10% fetal bovine serum and 1% Penicillin/
Streptomycin overnight and subsequently used for experiments up to the second 
day after isolation. Mast cells were identified visually using light microscopy 
(phase contrast) according to their distinct dark appearance and their characteris-
tic nucleus.
Electrophysiology. Patch-clamp experiments were performed in the tight-seal 
whole-cell configuration. High-resolution currents were acquired and recorded 
using EPC-9 (HEKA) and PatchMaster (HEKA). All voltages were corrected for 
a liquid junction potential of 10 mV between external and internal solutions. 
Currents were elicited by a ramp protocol from  − 100 to  + 100 mV over 50 ms 
acquired at 0.5 Hz and a holding potential of 0 mV. Inward current amplitudes were 
extracted at  − 80 mV, outward currents at  + 80 mV, normalized to cell size and 
plotted versus time of the experiment. Standard extracellular solution contained 
(in mM) 140 NaCl, 1 CaCl2, 2.8 KCl, 2 MgCl2, 10 HEPES–NaOH, 11 glucose (pH 
7.2, 300 mOsm). DVF intracellular solution contained (in mM) 140 Cs-glutamate,  
8 NaCl, 10 Cs-EGTA, 5 Na-EDTA (pH 7.2, 300 mOsm). The extracellular Mg2 + -
free application solution contained (in mM) 150 NaCl, 2.8 KCl, 3 CaCl2, 10 
HEPES–NaOH (pH 7.2, 300 mOsm). For Mg2 +  dose–response experiments, the 
current amplitudes were assessed from ramp currents at  + 80 mV obtained 300 s 
into the experiment. Nominally, Mg2 + -free extracellular solution for the MgCl2 
dose–response experiments contained 3 mM CaCl2 to substitute for the loss of 
divalents (in mM): 150 NaCl, 3 CaCl2, 2.8 KCl, 0 MgCl2, 10 HEPES–NaOH, 11 
glucose (pH 7.2, 300 mOsm); intracellular solution contained (in mM) 140 Cs-
glutamate, 8 NaCl, 10 Cs-BAPTA plus appropriate amount of MgCl2 was added,  
as calculated with WebMaxC.
Mg2 +  measurements in murine biological samples. The 4-month-old wild-type 
and TRPM7 + /∆kinase male mice were fed the control (0.1% Mg2 + ), severely Mg2 + -defi-
cient (0.003% Mg2 + ) or Mg2 + -supplemented (0.3%) diet for the appropriate period 
of the experiments. The magnesium concentrations in the experimental diets were 
determined by flame atomic absorption spectrophotometry (Perkin Elmer 800) 
at 285 nm. All mice had free access to distilled water and food. The semipurified 
diets contained the following (g kg − 1): casein 200, starch 650, corn oil 50, alphacel 
(cellulose) 50, DL-methionine 3, choline bitartrate 2, modified AIN-76 mineral 
mix 35, AIN-76A vitamin mix 10 (ICN Biomedicals). MgO was omitted from the 
mineral mix in magnesium-deficient diet. At the end of the experimental period, 
mice were anaesthetized with sodium pentobarbital (40 mg kg − 1 per body weight). 
Blood was obtained by puncturing the abdominal vein with a heparinized syringe. ARTICLE
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Blood samples were centrifuged at 1,000 g for 10 min at 20 °C, and the plasma and 
erythrocytes were then stored at  − 20 °C. Before killing the mice, 24-h urine sample 
was collected in metabolic cages and acidified with HCl (final pH  < 2).
For total magnesium determination, plasma, haemolysed erythrocytes and 
urine were diluted in 0.1% lanthanum chloride. For bones and feces, the samples 
were weighed, dry-ashed (10 h at 500 °C) and dissolved with concentrated 
HNO3 (14 M) and H2O2 (30%), on a heating plate until complete discoloration 
was achieved. The mineral solution was adjusted to 10 ml with distilled water 
and diluted with 0.1% lanthanum chloride as previously described27,28. The Mg2 +  
content was determined by atomic absorption spectrophotometry (Perkin Elmer 
AA800) at 28.5.
Isolation and culture of mouse ES cells. Isolation and culture of blastocyst-
derived stem cells were carried out according to the protocols described in the 
laboratory manual for manipulating the mouse embryo29. The media used for 
isolation and culture of ES cells was supplemented with 10 mM MgCl2. Primary 
cultures of mouse embryonic fibroblasts were used as feeder cells. To prepare 
mitotically inactive feeder cells, mouse embryonic fibroblasts were treated with 
Mitomycin C (Sigma). Images of ES cells were obtained with a phase-contrast 
×10 UplanFI objective using an Olympus IX70 microscope equipped with an 
environmental chamber at a temperature of 37 °C. Cell counting was performed 
using a hemocytometer.
Southern blotting. For Southern blot analysis, genomic DNA (10 µg) was digested 
with NcoI at 37 °C for 5 h. Digested DNA was loaded on 0.8% agarose gel and frac-
tionated by electrophoresis. After denaturing and neutralizing, DNA was transferred 
onto nylon membrane and crosslinked by ultraviolet light. The membrane was 
prehybridized at 42 °C for 4 h. 32P-labelled probe was then added and hybridization 
was performed at 42 °C overnight. The signal was detected by a phosphorimager.
Embryo collection and whole-mount in situ hybridizations. Whole-mount  
in situ hybridizations were performed as previously described30. DNA template was 
generated from mouse cDNA encoding Brachyury. The antisense RNA probe was 
synthesized from 1 µg of linearized cDNA and labelled with digoxigenin-UTP  
(Roche) using SP6 RNA polymerase (Promega). The transcription reaction was 
carried out at 37 °C for 2 h, followed by DNaseI treatment (Promega).
Embryos were dissected and fixed overnight in 4% paraformaldehyde (PFA) 
in phosphate-buffered saline (PBS) at 4 °C. After an overnight fixation tissues 
were washed in PBS containing 0.1% Tween-20 (PBT). Following dehydration, 
the tissues were stored in 100% methanol at  − 20 °C until use. After rehydration 
in PBT, embryos were bleached in 6% peroxide solution for 1 h, permeabilized 
with proteinase K (10 mg ml − 1) for 1 min, and postfixed in 4% PFA plus 0.2% 
glutaraldehyde. Proteinase K was inactivated with 0.2% glycine in PBT. Samples 
were incubated in hybridization buffer (50% formamide) for 2 h at 70 °C and 
then hybridized at the same temperature with 0.5 µg ml − 1 labelled RNA probe 
overnight. After posthybridization washes and RNase-A treatment (100 µg ml − 1), 
tissues were rinsed 3×5 min in maleic acid buffer (MAB; 0.1 M maleic acid, pH 
7.5, 0.15 M NaCl, 0.1% Tween-20 and 0.002 M levamisole) and then incubated in 
blocking buffer (MAB + 10% sheep serum, and 2% blocking reagent (Roche)), at 
room temperature for 3 h. Hybridized probes were incubated with preabsorbed 
anti-digoxigenin-AP (Roche) diluted 1:4,000 in blocking buffer (Roche) con-
taining 3 mg of mouse embryo powder overnight at 4 °C. Embryos were washed 
several times with MAB over a 24-h period at room temperature, and then 
developed with BM purple (Roche) colour substrate for 5–16 h.
Reactions were then stopped with 3×5 min PBT, postfixed in 4% PFA plus 0.2% 
glutaraldehyde, and stored in 80% glycerol in PBT.
Embryos were dissected and viewed on a LeicaMZ75 stereoscope. Embryos 
were photographed in 80% glycerol with a LeicaMZFLII stereoscope equipped 
with a Zeiss Axiocam HR digital camera, and Zeiss Axiovision version 4.5 imaging 
software.
Clasping test. Hindlimb clasping test was performed on day 12 of the  
Mg-deficient diet for both TRPM7-deficient and wild-type control mice.  
The clasping test evaluated the mice hindlimb response during suspension by 
the tail 10 cm above their home cage. Each mouse was observed during the first 
5 s of suspension and evaluated as having normal or abnormal movement and 
positioning of the limbs. When the mouse held its hindlimbs outward to steady 
itself, its hindlimb movements were considered normal and the mouse was 
defined as clasping negative. When the mouse made dystonic movement of the 
hindlimbs with clasping, where the limbs were pulled close to the body axis, its 
hindlimb movements were considered abnormal, and the mouse was defined as 
clasping positive.
Delayed hypersensitivity response measurements. Oxazolone was used as a 
contact-sensitizing agent. Oxazolone (0.5%) dissolved in acetone was applied on the   
shared mouse abdomen immediately before placing mice on experimental diets with  
various Mg2 +  content. Control animals were exposed to vehicle alone. Six days after 
sensitization, mice were challenged by epicutaneous application of 1% oxazolone in 
acetone on the ears. The swelling response was measured 24 h after challenge using 
an engineer’s micrometer. Calculations of the swelling response were carried out by 
comparing to the respective control groups not exposed to oxazolone. 
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